NLRP3 and gastric cancer: More and more studies have shown that NLRP3 inflammasome was closely associated with the progression of various tumors (such as gastric cancer (Castano-Rodriguez et al., 2014a; Castano-Rodriguez et al., 2014b; Zhang et al., 2022a), colorectal cancer (Dupaul-Chicoine et al., 2015; Perera et al., 2018; Shi et al., 2021b; Li et al., 2021; Marandi et al., 2021), liver cancer (Wei et al., 2014; Chen et al., 2020; Lee et al., 2021), etc.).